Unraveling The Benefits of Twice-Daily Chemoradiotherapy in LS-SCLC

Administering chemoradiotherapy (CRT) twice daily improved survival and reduced toxicity vs once-daily treatment among patients with limited-stage small cell lung cancer (LS-SCLC), according to Bin Gui, MD. However, it is necessary for…